Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al. Tur C, Montalban X Mult Scler. 2014 Jan 27. PMID: 24468818. Abstract CommentRecommendBookmarkWatch